Nemaura Medical, Inc. Common Stock
NMRD
NMRD was delisted on the 4th of January, 2024.
25 hedge funds and large institutions have $7.58M invested in Nemaura Medical, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
15,694% more capital invested
Capital invested by funds: $48K → $7.58M (+$7.53M)
2,200% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 1
733% more funds holding
Funds holding: 3 → 25 (+22)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.45M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$544K |
| 4 |
State Street
Boston,
Massachusetts
|
+$485K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$306K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$19.4K |
| 2 |
OIA
Optimum Investment Advisors
Chicago,
Illinois
|
-$9K |
NMRD Hedge Fund Activity: Q2 2020 in Review
25 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Nemaura Medical, Inc. Common Stock (NMRD) for Q2 2020, worth a combined $7.58M — up 15,694% from $48K a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new NMRD positions and 1 closed out — a net gain of 22 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $2.45M. The largest seller was UBS Group, cutting an estimated $19.4K.
- 25 institutional investors held Nemaura Medical, Inc. Common Stock (NMRD) as of Q2 2020, up from 3 in Q1 2020.
- Funds reported $7.58M of Nemaura Medical, Inc. Common Stock stock for Q2 2020, up 15,694% quarter-over-quarter.
- 23 funds opened new Nemaura Medical, Inc. Common Stock positions in Q2 2020 and 1 closed out, a net change of +22 holders.
- The largest Nemaura Medical, Inc. Common Stock buyer in Q2 2020 was BlackRock, an estimated $2.45M added.
- The largest Nemaura Medical, Inc. Common Stock seller in Q2 2020 was UBS Group, an estimated $19.4K sold.
Based on aggregated 13F filings for Q2 2020.